Tagayan, Nor-aiza U.
HRN: 01-70-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
MUPIROCIN 2%, 15G (TUBE)
09/26/2025
10/02/2025
TOPICAL
1ml
OD
SP CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes